Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel

Clinical trial NCT00527449 · COMPLETED

Trial details

NCT number: NCT00527449
Sponsor: Klinikum Weissenfels
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Breast Cancer

Start date: 2006-05-01
Primary completion: 2008-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.